Multiomic analysis of clonal development reveals new regulators of leukemic cell growth
Genes & Development · 2026
DOI: 10.1101/gad.353186.125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes & Development, 2026. Verfasst von Gracia Bonilla und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Gene Expression Regulation, Leukemic. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Mechanisms driving the increase in cell growth in developing leukemia are not fully understood. We focused on epigenomic regulation of this process by analyzing the changes of chromatin marks and gene expression in leukemic cell clones as they progressed toward increased proliferation in a mouse model of acute myeloid leukemia (AML). This progression was characterized by gradual modulation of chromatin states and gene expression across the genome, with a surprising preferential trend of reversing the prior changes associated with the origins of leukemia. Our analyses of this modulation in independently developing clones predicted a small set of potential growth regulators whose transcriptomic and epigenomic progression was consistent between clones and maintained both in vivo and ex vivo. We selected three of these genes as candidates ( Irx5 and Plag1 as growth suppressors and Smad1 as a driver) and successfully validated their causal growth effects by overexpression in mouse leukemic cells. Overexpression of the IRX5 gene in human MOLM13 leukemic cells suppressed cell growth both in vitro and in mouse xenografts. Public patient data confirmed expression levels of PLAG1 and SMAD1 as markers of AML status and survival, suggesting that multiomic analysis of evolving clones in a mouse model is a valuable predictive approach relevant to human AML.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
- Department of Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA.
- Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
- Harvard Stem Cell Institute, Cambridge, Massachusetts 02138, USA.
- Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, Massachusetts 02138, USA.
- Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Förderung
- NIDDK NIH HHS
- National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Bonilla, G., Morris, A., Kundu, S., DuCasse, A., Kirkpatrick, G., Milosevic, J., Jeffries, N. E., Chetal, K., Yvanovich, E. E., Zhao, T., Xia, J., Barghout, R., Scadden, D., Mansour, M. K., Kingston, R. E., Sykes, D. B., Mercier, F. E., & Sadreyev, R. I. (2026). Multiomic analysis of clonal development reveals new regulators of leukemic cell growth. Genes & Development. https://doi.org/10.1101/gad.353186.125
Vancouver
Bonilla G, Morris A, Kundu S, DuCasse A, Kirkpatrick G, Milosevic J, et al. Multiomic analysis of clonal development reveals new regulators of leukemic cell growth. Genes & Development. 2026. doi:10.1101/gad.353186.125
BibTeX
@article{Bonilla2026,
author = {Bonilla, Gracia and Morris, Alexander and Kundu, Sharmistha and DuCasse, Anthony and Kirkpatrick, Grace and Milosevic, Jelena and Jeffries, Nathan E and Chetal, Kashish and Yvanovich, Emma E and Zhao, Ting and Xia, Jun and Barghout, Rana and Scadden, David and Mansour, Michael K and Kingston, Robert E and Sykes, David B and Mercier, Francois E and Sadreyev, Ruslan I},
title = {Multiomic analysis of clonal development reveals new regulators of leukemic cell growth},
journal = {Genes & Development},
year = {2026},
doi = {10.1101/gad.353186.125}
}
EUVIMED